KHẢO SÁT BIẾN CHỨNG XUẤT HUYẾT TRÊN BỆNH NHÂN PHẪU THUẬT Ổ BỤNG SỬ DỤNG THUỐC CHỐNG ĐÔNG TRONG DỰ PHÒNG THUYÊN TẮC HUYẾT KHỐI TĨNH MẠCH TẠI KHOA NGOẠI TIÊU HÓA BỆNH VIỆN NHÂN DÂN GIA ĐỊNH

Abstract

Research objectives: Frequency of hemorrhagic complications when using anticoagulants in the prevention of VTE in abdominal surgery patients at the department of gastrointestinal medicine of the People's Hospital of Gia Định. Object and method of research: The study described a series of cases, carried out on 69 medical records, in accordance with the research standards, treated at the Gastroenterology Surgery Department of the Gia Dinh People's Hospital in the period 1/2021-6/2022. Results: In our study, the bleeding rate was 7.2% with the average duration of anticoagulant use until bleeding was 3.2 days. The rates of skin hemorrhage was 4.2%, gastrointestinal bleeding was 1.5% and wound blood clotting was 1.5%, where the enoxaparin-resistant group had a 9.1% higher rate of hypertension than the gemapaxane-resistant group with a bleeding rate of 6.4%, but the difference was not statistically significant (p>0,05). We analyzed monovariants to find factors that influence the risk of bleeding such as age, gender, BMI, concomitant diseases, type of surgery, but we did not record any factors that affect the possibility of a bleeding (p>0,05). Conclusion: The bleeding rate was 7,2% with the average duration of anticoagulant use until bleeding was 3,2 days. Factors such as age, gender, BMI, concomitant diseases, and type of surgery, did not affect the possibility of bleeding when using anticoagulants (p >0,05).